Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus

NCT04801199 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

355

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Type 2 Diabetes Mellitus

Interventions

DRUG: CPL-2009-0031 140 mg
DRUG: Sitagliptin 100mg

Sponsor

Cadila Pharnmaceuticals

Collaborators

[object Object]